Antibody–drug conjugates (ADCs) are designed to bring the precision of targeted therapy together with the potency of cytotoxic payloads. Naturally, much of the focus during ADC development has been on binding - ensuring that the antibody component efficiently and specifically recognizes its antigen ...
In this "Ask the Expert" interview, Dr. Javier Frias Aldeguer, Senior ...
Last week, the FDA announced a transformative shift in drug ...
In this edition of Ask the Expert, featuring Dr. Yasmine Abouleila, ...
This "Ask the Experts" feature delves into the pressing inquiries ...
Inflammatory Bowel Disease (IBD) is a complex condition that affects ...
.jpg)
Discover the 6 hallmarks of stemness in adult tissue Mammalian organ ...
.jpg)
In this post of our "Ask the Experts" series, we provide ...
Discover how patient-derived organoids can revolutionize oncology ...
Explore what the new legislative bill means for the future of ...